Reported 213,264 shares, down 30,802 (12.6%) from the prior quarter.
Reported value -9.4%; share count -12.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 1727000 |
| 2022-03-31 | 1565000 |
| 2022-06-30 | 1334000 |
| 2022-09-30 | 2584000 |
| 2022-12-31 | 1933464 |
| 2023-03-31 | 2209314 |
| 2023-06-30 | 2883222 |
| 2023-09-30 | 1906257 |
| 2023-12-31 | 1755705 |
| 2024-03-31 | 3833054 |
| 2024-06-30 | 2640637 |
| 2024-09-30 | 2469188 |
| 2024-12-31 | 996217 |
| 2025-03-31 | 355970 |
| 2025-06-30 | 292198 |
| 2025-09-30 | 0 |
| 2025-09-30 | 1005333 |
| 2025-12-31 | 916627 |
| 2026-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2026 | Reduced | 0 | -161,378 (-100.0%) | 0 | $0 | 2026-05-15 | |
| Q4 2025 | Reduced | 161,378 | -2,892 (-1.8%) | < 0.01% | $916,627 | 2026-02-13 | |
| Q3 2025 | New | 164,270 | +164,270 (0.0%) | < 0.01% | $1,005,333 | 2025-11-14 | |
| Q3 2025 | Reduced | 0 | -912,834 (-100.0%) | 0 | $0 | 2025-11-14 | |
| Q2 2025 | Added | 912,834 | +33,898 (3.9%) | < 0.01% | $292,198 | 2025-08-15 | |
| Q1 2025 | Reduced | 878,936 | -60,891 (-6.5%) | < 0.01% | $355,970 | 2025-05-15 | |
| Q4 2024 | Reduced | 939,827 | -59,844 (-6.0%) | < 0.01% | $996,217 | 2025-02-14 | |
| Q3 2024 | Added | 999,671 | +63,275 (6.8%) | < 0.01% | $2,469,188 | 2024-11-14 | |
| Q2 2024 | Reduced | 936,396 | -5,386 (-0.6%) | < 0.01% | $2,640,637 | 2024-08-14 | |
| Q1 2024 | Reduced | 941,782 | -122,282 (-11.5%) | < 0.01% | $3,833,054 | 2024-05-15 | |
| Q4 2023 | Added | 1,064,064 | +561,094 (111.6%) | < 0.01% | $1,755,705 | 2024-02-13 | |
| Q3 2023 | Reduced | 502,970 | -21,252 (-4.1%) | < 0.01% | $1,906,257 | 2023-11-15 | |
| Q2 2023 | Added | 524,222 | +10,428 (2.0%) | < 0.01% | $2,883,222 | 2023-08-14 | |
| Q1 2023 | Added | 513,794 | +21,818 (4.4%) | < 0.01% | $2,209,314 | 2023-05-15 | |
| Q4 2022 | Added | 491,976 | +5,210 (1.1%) | < 0.01% | $1,933,464 | 2023-02-14 | |
| Q3 2022 | Added | 486,766 | +283,337 (139.3%) | < 0.01% | $2,584,000 | 2022-11-14 | |
| Q2 2022 | Reduced | 203,429 | -9,835 (-4.6%) | < 0.01% | $1,334,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 213,264 | -30,802 (-12.6%) | < 0.01% | $1,565,000 | 2022-05-13 | |
| Q4 2021 | Added | 244,066 | +7,270 (3.1%) | < 0.01% | $1,727,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
103 managers reported GENERATION BIO CO for Q1 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC MD | Added | 8,763,691 | +116,570 | < 0.01% | $64,325,000 | 8 qtrs |
| FMR LLC | Added | 8,550,767 | +14,305 | < 0.01% | $62,762,631 | 8 qtrs |
| Atlas Venture Life Science Advisors LLC | Unchanged | 8,278,876 | 0 | 7.68% | $60,767,000 | 2 qtrs |
| Bellevue Group AG | Reduced | 3,682,180 | -190,000 | 0.31% | $27,027,000 | 8 qtrs |
| VANGUARD GROUP INC | Reduced | 3,549,177 | -45,284 | < 0.01% | $26,051,000 | 8 qtrs |
| FARALLON CAPITAL MANAGEMENT LLC | Unchanged | 3,500,000 | 0 | 0.12% | $25,690,000 | 8 qtrs |
| BlackRock Inc | Added | 3,168,702 | +1,157 | < 0.01% | $23,260,000 | 8 qtrs |
| Artal Group S A | Unchanged | 2,814,191 | 0 | 0.86% | $20,656,000 | 8 qtrs |
| BVF INC IL | Added | 2,802,950 | +2,613,900 | 0.82% | $20,574,000 | 2 qtrs |
| Yiheng Capital Management L P | Added | 2,597,631 | +622,485 | 0.87% | $19,067,000 | 4 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2022
- Filed
- May 13, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 211,904
- Shared
- 868
- None
- 492
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.